RFI-641, a Potent Respiratory Syncytial Virus Inhibitor

Human respiratory syncytial virus (RSV), a paramyxovirus, is a major cause of acute upper and lower respiratory tract infections in infants, young children, and adults. RFI-641 is a novel anti-RSV agent with potent in vitro and in vivo activity. RFI-641 is active against both RSV type A and B strain...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Huntley, Clayton C., Weiss, William J., Gazumyan, Anna, Buklan, Aron, Feld, Boris, Hu, William, Jones, Thomas R., Murphy, Timothy, Nikitenko, Antonia A., O'Hara, Bryan, Prince, Gregory, Quartuccio, Susan, Raifeld, Yuri E., Wyde, Philip, O'Connell, John F.
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 2002
Assuntos:	Antiviral Agents
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127488/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11850270/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.3.841-847.2002
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!